Drug Trial Radar · NCT03291067
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Last checked: Nov 20, 2026Latest source record: Jan 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
375
Actual
Start
Oct 9, 2017
Primary completion
Oct 19, 2018
Study completion Nov 9, 2018
Sponsor
- Lead sponsor
- Tanabe Pharma America, Inc.Industry
- Sponsor type
- Industry
- First posted
- Sep 25, 2017
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the efficacy and safety of MT-8554 for treatment of vasomotor symptoms (VMS) associated with menopause.
Conditions
- Menopause Hot Flashes
Interventions
MT-8554 1mgDrug
MT-8554 1mg QD, oral, 12 weeks
MT-8554 5mgDrug
MT-8554 5mg QD, oral, 12 weeks
MT-8554 10mgDrug
MT-8554 10mg QD, oral, 12 weeks
PlaceboDrug
Placebo QD, oral, 12 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in the Average Daily Frequency of Moderate to Severe VMS at Weeks 4 and 12Time frame: Baseline, Weeks 4 and 12
- Change From Baseline in the Average Daily Severity Score of Mild to Severe VMS at Weeks 4 and 12Time frame: Baseline, Weeks 4 and 12
Locations
63 sites in 1 country. Site status is shown where the registry gives one.
Research Site
Birmingham, Alabama
Research Site
Dothan, Alabama
Research Site
Phoenix, Arizona
Research Site
Norwalk, California
Research Site
Sacramento, California
Research Site
San Diego, California
Research Site
Denver, Colorado
Research Site
New London, Connecticut
Research Site
New London, Connecticut
Research Site
Aventura, Florida
Research Site
Clearwater, Florida
Research Site
Crystal River, Florida
Research Site
Fort Myers, Florida
Research Site
Hialeah, Florida
Research Site
Hialeah, Florida
Research Site
Jacksonville, Florida
Research Site
Jacksonville, Florida
Research Site
Jupiter, Florida
Research Site
Miami, Florida
Research Site
Miami, Florida
Research Site
Miami, Florida
Research Site
Orlando, Florida
Research Site
Orlando, Florida
Research Site
Ponte Vedra, Florida
Research Site
Port Saint Lucie, Florida
Research Site
Sarasota, Florida
Research Site
Sarasota, Florida
Research Site
Wellington, Florida
Research Site
West Palm Beach, Florida
Research Site
Sandy Springs, Georgia
Research Site
Idaho Falls, Idaho
Research Site
Ankeny, Iowa
Research Site
Wichita, Kansas
Research Site
Marrero, Louisiana
Research Site
Metairie, Louisiana
Research Site
Baltimore, Maryland
Research Site
Kalamazoo, Michigan
Research Site
Saginaw, Michigan
Research Site
Saginaw, Michigan
Research Site
Kansas City, Missouri
Showing 40 of 63 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.